Cannabis Stock Bankruptcies Are Rising: Is Aurora Cannabis (TSX:ACB) Vulnerable?

Canadian cannabis stocks are under considerable pressure and Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is among the most vulnerable.

| More on:
Question marks in a pile

Image source: Getty Images

Canadian cannabis stocks have suffered sharp losses because of the coronavirus pandemic. The largest cannabis ETF, the ETFMG Alternative Harvest ETF, has lost 33% since the start of 2020.  The ETF was led lower by its sixth-largest stock holding Aurora Cannabis (TSX:ACB)(NYSE:ACB), which has lost a whopping 64%.

After the latest developments, the market has priced Aurora for bankruptcy. Canada’s third-largest cultivator by revenue is trading at less than a twelfth of its 52-week high.

Poor outlook for cannabis stocks

The outlook for cannabis stocks is poor, especially after the marijuana bubble burst in late April 2019. After almost two years of delivering super-sized returns, many cannabis companies are struggling to grow as anticipated. A combination of non-existent profitability, large capital spending, smaller-than-anticipated market, and dwindling liquidity is weighing on their outlook.

These issues are being magnified by the coronavirus pandemic. Governments across the world have shuttered non-essential services, including marijuana dispensaries in many jurisdictions. They have also implemented restrictions on movement and travel bans, which are further weighing on the consumption of legal cannabis products.

It has also seen governments focus on issues more urgent than legalizing the medical and recreational use of marijuana.

These factors represent a poor development for companies which have been struggling with profitability, triggering bankruptcies among cannabis stocks.

Weak sales growth

A distinct lack of profitability is a long-term issue for many cannabis stocks. This is being impacted by the global legal marijuana market being far smaller than originally anticipated by the industry. Aurora reported a massive $1.3 billion fiscal second quarter 2020 loss, which was more than five-times greater than the $239 million loss reported for the same period in 2019.

The cultivator is struggling with liquidity. Aurora finished March 2020 with $205 million in cash compared to $544 million of long-term debt. Earlier this year, investors were warned that Aurora, because of its liquidity issues, could fail to meet its debt covenants.

In response, Aurora renegotiated its credit facilities seeing the EBITDA covenant removed but the size of the facility was reduced by $141.5 million, further impacting its liquidity.

Aurora’s lack of capital and liquidity saw it announce almost two weeks ago that it intends to raise up to US$350 million in equity capital to bolster its coffers, which will likely have a dilutive event for existing shareholders. It’s difficult to see how Aurora can successfully complete such an action without offering the stock at a deep discount to potential subscribers.

The company believes this will address the risks surrounding its debt covenants and need for capital to continue developing its operations.

Risks ahead for cannabis stocks

While Aurora’s short-term position is improving, there are still considerable risks associated with its operations and there are signs of more to come. Declining margins weighed on Aurora’s second quarter performance.

The cultivator also recorded just over $1 billion of impairment charges for the second quarter. The value of many assets, notably goodwill and cultivating operations, in the industry appear overcooked.

There could well be further write-downs and impairment charges ahead for Aurora. The cannabis cultivator is still working out how to unlock value from its business and complete the transformation of its business.

Foolish takeaway

Cannabis stocks are under considerable pressure. The current adverse circumstances sparked by the coronavirus pandemic could spark bankruptcies in an already stressed legal cannabis industry.

Along with overall poor outlook for Canada’s legal marijuana stocks Aurora is one of the most vulnerable. A likely outcome from economic downturn triggered by the coronavirus is a reduction in sales and hence cash flow.

This will apply further pressure to cultivators like Aurora, which are already experiencing liquidity issues. When coupled with Aurora’s plans to raise equity capital, through what will likely be a dilutive offering, it’s difficult to see its stock rallying.

Many of these short-term issues will morph into long-term headwinds that could challenge Aurora’s ability to remain a going concern.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Hexo Stock Jumps 10% on Definitive Tilray Deal

Hexo (TSX:HEXO)(NASDAQ:HEXO) stock jumped 10% on Monday, as its deal with Tilray (TSX:TLRY)(NASDAQ:TLRY) stock became official.

Read more »

edit Jars of marijuana
Cannabis Stocks

Down 97% From Record Highs, Is Sundial Stock a Buy Right Now?

Despite the 97% decline in Sundial stock from its record high, it remains a risky bet for long-term investors due…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Tilray Stock Rallied After its Q3 Results

Here's why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Tuesday, March 29

TSX investors may want to keep an eye on the latest consumer confidence and job openings data from the U.S.…

Read more »